• Member Statistics

    • 817,799 Colleagues-to-Date [Sponsored by a generous R&D grant from iMBA, Inc.]
  • David E. Marcinko [Editor-in-Chief]

    As a former Dean and appointed University Professor and Endowed Department Chair, Dr. David Edward Marcinko MBA was a NYSE broker and investment banker for a decade who was respected for his unique perspectives, balanced contrarian thinking and measured judgment to influence key decision makers in strategic education, health economics, finance, investing and public policy management.

    Dr. Marcinko is originally from Loyola University MD, Temple University in Philadelphia and the Milton S. Hershey Medical Center in PA; as well as Oglethorpe University and Emory University in Georgia, the Atlanta Hospital & Medical Center; Kellogg-Keller Graduate School of Business and Management in Chicago, and the Aachen City University Hospital, Koln-Germany. He became one of the most innovative global thought leaders in medical business entrepreneurship today by leveraging and adding value with strategies to grow revenues and EBITDA while reducing non-essential expenditures and improving dated operational in-efficiencies.

    Professor David Marcinko was a board certified surgical fellow, hospital medical staff President, public and population health advocate, and Chief Executive & Education Officer with more than 425 published papers; 5,150 op-ed pieces and over 135+ domestic / international presentations to his credit; including the top ten [10] biggest drug, DME and pharmaceutical companies and financial services firms in the nation. He is also a best-selling Amazon author with 30 published academic text books in four languages [National Institute of Health, Library of Congress and Library of Medicine].

    Dr. David E. Marcinko is past Editor-in-Chief of the prestigious “Journal of Health Care Finance”, and a former Certified Financial Planner® who was named “Health Economist of the Year” in 2010. He is a Federal and State court approved expert witness featured in hundreds of peer reviewed medical, business, economics trade journals and publications [AMA, ADA, APMA, AAOS, Physicians Practice, Investment Advisor, Physician’s Money Digest and MD News] etc.

    Later, Dr. Marcinko was a vital and recruited BOD  member of several innovative companies like Physicians Nexus, First Global Financial Advisors and the Physician Services Group Inc; as well as mentor and coach for Deloitte-Touche and other start-up firms in Silicon Valley, CA.

    As a state licensed life, P&C and health insurance agent; and dual SEC registered investment advisor and representative, Marcinko was Founding Dean of the fiduciary and niche focused CERTIFIED MEDICAL PLANNER® chartered professional designation education program; as well as Chief Editor of the three print format HEALTH DICTIONARY SERIES® and online Wiki Project.

    Dr. David E. Marcinko’s professional memberships included: ASHE, AHIMA, ACHE, ACME, ACPE, MGMA, FMMA, FPA and HIMSS. He was a MSFT Beta tester, Google Scholar, “H” Index favorite and one of LinkedIn’s “Top Cited Voices”.

    Marcinko is “ex-officio” and R&D Scholar-on-Sabbatical for iMBA, Inc. who was recently appointed to the MedBlob® [military encrypted medical data warehouse and health information exchange] Advisory Board.

    entrepreneur

    Frontal_lobe_animation

  • ME-P Information & Content Channels

  • ME-P Archives Silo [2006 – 2020]

  • Ann Miller RN MHA [Managing Editor]

    ME-P SYNDICATIONS:
    WSJ.com,
    CNN.com,
    Forbes.com,
    WashingtonPost.com,
    BusinessWeek.com,
    USNews.com, Reuters.com,
    TimeWarnerCable.com,
    e-How.com,
    News Alloy.com,
    and Congress.org

    Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners(TM)

    Product Details

    Product Details

    Product Details

  • CERTIFIED MEDICAL PLANNER® program

    New "Self-Directed" Study Option SinceJanuary 1st, 2020
  • Most Recent ME-Ps

  • PodiatryPrep.org


    BOARD CERTIFICATION EXAM STUDY GUIDES
    Lower Extremity Trauma
    [Click on Image to Enlarge]

  • ME-P Free Advertising Consultation

    The “Medical Executive-Post” is about connecting doctors, health care executives and modern consulting advisors. It’s about free-enterprise, business, practice, policy, personal financial planning and wealth building capitalism. We have an attitude that’s independent, outspoken, intelligent and so Next-Gen; often edgy, usually controversial. And, our consultants “got fly”, just like U. Read it! Write it! Post it! “Medical Executive-Post”. Call or email us for your FREE advertising and sales consultation TODAY [770.448.0769]

    Product Details

    Product Details

  • Medical & Surgical e-Consent Forms

    ePodiatryConsentForms.com
  • iMBA R&D Services

    Commission a Subject Matter Expert Report [$2500-$9999]January 1st, 2020
    Medical Clinic Valuations * Endowment Fund Management * Health Capital Formation * Investment Policy Statement Analysis * Provider Contracting & Negotiations * Marketplace Competition * Revenue Cycle Enhancements; and more! HEALTHCARE FINANCIAL INDUSTRIAL COMPLEX
  • iMBA Inc., OFFICES

    Suite #5901 Wilbanks Drive, Norcross, Georgia, 30092 USA [1.770.448.0769]. Our location is real and we are now virtually enabled to assist new long distance clients and out-of-town colleagues.

  • ME-P Publishing

  • SEEKING INDUSTRY INFO PARTNERS?

    If you want the opportunity to work with leading health care industry insiders, innovators and watchers, the “ME-P” may be right for you? We are unbiased and operate at the nexus of theoretical and applied R&D. Collaborate with us and you’ll put your brand in front of a smart & tightly focused demographic; one at the forefront of our emerging healthcare free marketplace of informed and professional “movers and shakers.” Our Ad Rate Card is available upon request [770-448-0769].

  • Reader Comments, Quips, Opinions, News & Updates

  • Start-Up Advice for Businesses, DRs and Entrepreneurs

    ImageProxy “Providing Management, Financial and Business Solutions for Modernity”
  • Up-Trending ME-Ps

  • Capitalism and Free Enterprise Advocacy

    Whether you’re a mature CXO, physician or start-up entrepreneur in need of management, financial, HR or business planning information on free markets and competition, the "Medical Executive-Post” is the online place to meet for Capitalism 2.0 collaboration. Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds. THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
  • OIG Fraud Warnings

    Beware of health insurance marketplace scams OIG's Most Wanted Fugitives at oig.hhs.gov

Do Foreclosures Promote Clandestine Pot Houses?

Join Our Mailing List

About Indoor Marijuana Grow Farms and Labs

[By DEA Agent]

Marijuana growers are shifting to the suburbs from rural and commercial areas, helped by a housing crisis that created a glut of affordable home and basement farms like the images below.

BASEMENT POT HOUSE

CLOSE-UP VIEW

Assesment

Unlike traditional earthen farming methods in the photos above, hydroponic grow boxes may be large stealth cabinets that produce fresh marijuana, or other herbs and vegetables, in an indoor garden and grow on water, nutrients and grow-lights alone.

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Product DetailsProduct DetailsProduct Details

Product Details  Product Details

Product Details

5 Responses

  1. Adolescent pot use leaves lasting mental deficits

    Individuals may lose IQ points later in life if they smoke marijuana before age 18, according to a study that follows a survey showing use of the drug has increased in this age group for four straight years.

    http://www.businessweek.com/news/2012-08-27/pot-smoking-teens-may-become-slower-thinking-adults

    The research reported in the Proceedings of the National Academy of Sciences found an average decline of eight points on IQ tests done at age 13 and 38 among those who began using marijuana as teenagers. That compared with a slight increase in those who never used it.

    Barry

    Like

  2. Altria’s Untapped $40 Billion Market: Marijuana in the U.S.

    Marlboro cigarette maker Altria controls 50.9% of the U.S. cigarette market. The company is still gaining market share; one year ago the company controlled 50.7% of the U.S. cigarette market.

    http://www.msn.com/en-us/money/inside-the-ticker/altrias-untapped-dollar40-billion-market-marijuana-in-the-us/ar-BBdwXAM?ocid=iehp

    The U.S. cigarette industry is slowly declining as the negative health consequences of smoking become common knowledge.

    Chong
    http://www.amazon.com/Insurance-Management-Strategies-Physicians-Advisors/dp/0763733423/ref=sr_1_3?ie=UTF8&s=books&qid=1275315795&sr=1-3

    Like

  3. Bank of America Merrill Lynch Is High On Marijuana

    Put this in your pipeline: Bank of America Merrill Lynch sees massive investment potential in weed. In an in-depth and pun-filled research report, the firm estimated that medical marijuana is currently a $2.9 billion industry that could at least double as more states move towards legalization.

    “In our view, scientific, clinical and anecdotal evidence support medicinal cannabis while recent media attention has contributed to public awareness,” the report states. The report examines everything from how marijuana products are produced, used and sold to how drug companies are getting involved to even the chemistry of how pot achieves its effect.

    http://wealthmanagement.com/blog/merrill-lynch-high-marijuana

    The firm singled out the company GW Pharmaceuticals as being particularly attractive for conducting clinically approved trials of a cannabis based drug for children with epilepsy. Merrill said it’s “bullish on the cannabis testing market,” especially the development of new equipment for testing weed’s quality and potency.

    Ann Miller RN MHA

    Like

  4. Marijuana Has Downsides

    No one should be under the impression that marijuana is harmless. The potential downsides are well known. Nor should anyone be irrationally exuberant about its upsides. It’s not a wonder drug, and the proven benefits are also minimal.

    We should be honest about what we do and don’t know. We need more research. It’s true that much of the literature around marijuana focuses on the negative, but that’s “largely due to funding priorities over the last severaldecades,” Dr. Cooper said.

    In the report she worked on, only 40 of the 450 pages were about the therapeutic effects of cannabis and cannabinoids, she said, while the other sections were related largely to the negative health outcomes.

    She added, “With increased awareness of the clinical potential of cannabinoids, research priorities have shifted to include studying this area” in the last few years.

    It’s perfectly natural to be concerned that as cannabis products become legal in more states, they will affect more people.

    Many of the experts who have done the work highlighted here are still nervous about how we might proceed. No one thinks that children or adolescents should use marijuana. There’s little regulation right now, and there’s potentialfor the drug to be mixed with other substances to increase its addictive properties. Advertising will probably make claims that will be out of line with reality.

    We should be clear about what we’re talking about here, though. Adults will make decisions on how to use it just as they do with similar products like alcohol and tobacco. Both are moredangerous than marijuana, and it’s not even close.

    Anecdotes can make compelling cases, but they don’t necessarily lead to thoughtful outcomes.

    @aaronecarroll
    via Ann Miller RN MHA

    Like

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: